3-Methyladenine induces cell death and its interaction with chemotherapeutic drugs is independent of autophagy

Biochemical and Biophysical Research Communications

Volumn 432, Issue 1, 2013, Pages 5-9

  Sheng, Yue ^a   Sun, Bo ^a   Guo, Wen Ting ^a   Zhang, Yong Hui ^a   Liu, Xiao ^a   Xing, Yue ^a   Dong, De Li ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

3 Methyladenine; Autophagy; Cancer cells; Chemotherapy

Indexed keywords

3 METHYLADENINE; ANTINEOPLASTIC AGENT; FLUOROURACIL; PLATINUM DERIVATIVE; TAMOXIFEN; TETRAZOLIUM;

ARTICLE; AUTOPHAGY; CELL DEATH; CELL VIABILITY; DOSE RESPONSE; HELA CELL; HUMAN; HUMAN CELL; NICK END LABELING; PRIORITY JOURNAL; STAINING;

ADENINE; ANTINEOPLASTIC AGENTS; AUTOPHAGY; CISPLATIN; DRUG AGONISM; DRUG SYNERGISM; FLUOROURACIL; HELA CELLS; HUMANS; MCF-7 CELLS; MICROTUBULE-ASSOCIATED PROTEINS; TAMOXIFEN;

EID: 84875364684     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.01.106     Document Type: Article

References (23)

1. Maiuri M.C., Zalckvar E., Kimchi A., Kroemer G. Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat. Rev. Mol. Cell. Biol. 2007, 8:741-752.
2. Dalby K.N., Tekedereli I., Lopez-Berestein G., Ozpolat B. Targeting the prodeath and prosurvival functions of autophagy as novel therapeutic strategies in cancer. Autophagy 2010, 6:322-329.
3. Nemchenko A., Chiong M., Turer A., Lavandero S., Hill J.A. Autophagy as a therapeutic target in cardiovascular disease. J. Mol. Cell. Cardiol. 2011, 51:584-593.
4. Son J.H., Shim J.H., Kim K.H., Ha J.Y., Han J.Y. Neuronal autophagy and neurodegenerative diseases. Exp. Mol. Med. 2012, 44:89-98.
5. White E. Autophagic cell death unraveled: pharmacological inhibition of apoptosis and autophagy enables necrosis. Autophagy 2008, 4:399-401.
6. Choi K.S. Autophagy and cancer. Exp. Mol. Med. 2012, 44:109-120.
7. Yang P.M., Liu Y.L., Lin Y.C., Shun C.T., Wu M.S., Chen C.C. Inhibition of autophagy enhances anticancer effects of atorvastatin in digestive malignancies. Cancer Res. 2010, 70:7699-7709.
8. Chen S., Rehman S.K., Zhang W., Wen A., Yao L., Zhang J. Autophagy is a therapeutic target in anticancer drug resistance. Biochim. Biophys. Acta 1806, 2010:220-229.
9. Seglen P.O., Gordon P.B. 3-Methyladenine: specific inhibitor of autophagic/lysosomal protein degradation in isolated rat hepatocytes. Proc. Natl. Acad. Sci. USA 1982, 79:1889-1892.
10. Katayama M., Kawaguchi T., Berger M.S., Pieper R.O. DNA damaging agent-induced autophagy produces a cytoprotective adenosine triphosphate surge in malignant glioma cells. Cell Death Differ. 2007, 14:548-558.
11. Li J., Hou N., Faried A., Tsutsumi S., Takeuchi T., Kuwano H. Inhibition of autophagy by 3-MA enhances the effect of 5-FU-induced apoptosis in colon cancer cells. Ann. Surg. Oncol. 2009, 16:761-771.
12. Li J., Qin Z., Liang Z. The prosurvival role of autophagy in Resveratrol-induced cytotoxicity in human U251 glioma cells. BMC Cancer 2009, 9:215.
13. Wu Y.T., Tan H.L., Shui G., Bauvy C., Huang Q., Wenk M.R., Ong C.N., Codogno P., Shen H.M. Dual role of 3-methyladenine in modulation of autophagy via different temporal patterns of inhibition on class I and III phosphoinositide 3-kinase. J. Biol. Chem. 2010, 285:10850-10861.
14. Heckmann B.L., Yang X., Zhang X., Liu J. The autophagic inhibitor 3-methyladenine (3-MA) potently stimulates PKA-dependent lipolysis in adipocytes. Br. J. Pharmacol. 2012, 10.1111/j.1476-5381.2012.02110.x.
15. Li Q., Zhang Y., Sheng Y., Huo R., Sun B., Teng X., Li N., Zhu J.X., Yang B.F., Dong D.L. Large T-antigen up-regulates Kv4.3 K(+) channels through Sp1, and Kv4.3 K+ channels contribute to cell apoptosis and necrosis through activation of calcium/calmodulin-dependent protein kinase II. Biochem. J. 2012, 441:859-867.
16. Chou T.C., Motzer R.J., Tong Y., Bosl G.J. Computerized quantitation of synergism and antagonism of taxol, topotecan, and cisplatin against human teratocarcinoma cell growth: a rational approach to clinical protocol design. J. Natl. Cancer Inst. 1994, 86:1517-1524.
17. Chou T.C., Talalay P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv. Enzyme Regul. 1984, 22:27-55.
18. Tanida I., Ueno T., Kominami E. LC3 and autophagy. Methods Mol. Biol. 2008, 445:77-88.
19. Hou H., Zhang Y., Huang Y., Yi Q., Lv L., Zhang T., Chen D., Hao Q., Shi Q. Inhibitors of phosphatidylinositol 3'-kinases promote mitotic cell death in Hela cells. PLoS One 2012, 7:e35665.
20. Chen Y., Azad M.B., Gibson S.B. Superoxide is the major reactive oxygen species regulating autophagy. Cell Death Differ. 2009, 16:1040-1052.
21. Maruyama R., Goto K., Takemura G., Ono K., Nagao K., Horie T., Tsujimoto A., Kanamori H., Miyata S., Ushikoshi H., Nagashima K., Minatoguchi S., Fujiwara T., Fujiwara H. Morphological and biochemical characterization of basal and starvation-induced autophagy in isolated adult rat cardiomyocytes. Am. J. Physiol. Heart Circ. Physiol. 2008, 295:H1599-H1607.
22. Xi G., Hu X., Wu B., Jiang H., Young C.Y., Pang Y., Yuan H. Autophagy inhibition promotes paclitaxel-induced apoptosis in cancer cells. Cancer Lett. 2011, 307:141-148.
23. Ito S., Koshikawa N., Mochizuki S., Takenaga K. 3-Methyladenine suppresses cell migration and invasion of HT1080 fibrosarcoma cells through inhibiting phosphoinositide 3-kinases independently of autophagy inhibition. Int. J. Oncol. 2007, 31:261-268.